Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 8:13 pm Unchanged |
2025-03-31 | 13G | InspireMD, Inc. NSPR |
ORBIMED ADVISORS LLC | 2,133,405 7.200% |
0 (Unchanged) |
Filing History |
| 2025-05-15 4:32 pm Purchase |
2025-03-31 | 13G | InspireMD, Inc. NSPR |
Nantahala Capital Management LLC | 3,037,935 9.990% |
328,817 (+12.14%) |
Filing History |
| 2025-05-12 1:44 pm Sale |
2025-03-31 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors Inc. | 9,713,171 7.700% |
-220,793 (-2.22%) |
Filing History |
| 2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | InspireMD, Inc. NSPR |
Nantahala Capital Management LLC | 2,709,118 9.990% |
101,234 (+3.88%) |
Filing History |
| 2025-02-07 11:24 am Purchase |
2024-12-31 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors Inc. | 9,933,964 9.900% |
2,495,783 (+33.55%) |
Filing History |
| 2024-12-04 4:31 pm Purchase |
2024-11-27 | 13G | InspireMD, Inc. NSPR |
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 1,411,636 5.220% |
1,411,636 (New Position) |
Filing History |
| 2024-11-14 6:35 pm Unchanged |
2024-09-30 | 13G | InspireMD, Inc. NSPR |
ORBIMED ADVISORS LLC | 2,133,405 8.300% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | InspireMD, Inc. NSPR |
Nantahala Capital Management LLC | 2,607,884 9.990% |
445,492 (+20.60%) |
Filing History |
| 2024-10-28 4:02 pm Unchanged |
2024-09-30 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors Inc. | 7,438,181 9.800% |
0 (Unchanged) |
Filing History |
| 2024-07-11 5:48 pm Sale |
2024-06-28 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors Inc. | 7,438,181 9.900% |
-21,747 (-0.29%) |
Filing History |
| 2024-05-17 12:58 pm Sale |
2024-04-24 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors Inc. | 7,459,928 9.900% |
-1,528,390 (-17.00%) |
Filing History |
| 2024-04-25 7:30 pm Unchanged |
2024-03-31 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors Inc. | 8,988,318 9.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 9:33 pm Unchanged |
2023-12-31 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors Inc. | 8,988,318 9.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 7:41 pm Purchase |
2023-12-31 | 13G | InspireMD, Inc. NSPR |
ORBIMED ADVISORS LLC | 2,133,405 9.900% |
2,133,405 (New Position) |
Filing History |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | InspireMD, Inc. NSPR |
Nantahala Capital Management LLC | 2,162,392 9.900% |
2,162,392 (New Position) |
Filing History |
| 2023-06-16 4:15 pm Purchase |
2023-06-08 | 13D | InspireMD, Inc. NSPR |
Shore Craig | 1,700,159 8.010% |
1,700,159 (New Position) |
Filing History |
| 2023-06-07 5:33 pm Purchase |
2023-06-01 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors Inc. | 8,988,318 9.900% |
8,988,318 (New Position) |
Filing History |
| 2023-05-24 4:31 pm Purchase |
2023-05-16 | 13G | InspireMD, Inc. NSPR |
Soleus Private Equity Fund III, L.P. | 2,199,118 9.900% |
2,199,118 (New Position) |
Filing History |
| 2023-05-22 4:15 pm Purchase |
2023-05-12 | 13G | InspireMD, Inc. NSPR |
Marshall Wace North America L.P. | 1,860,405 9.900% |
1,860,405 (New Position) |
Filing History |
| 2022-02-11 5:04 pm Purchase |
2021-12-31 | 13G | InspireMD, Inc. NSPR |
Lind Global Macro Fund LP | 177,333 2.100% |
177,333 (New Position) |
Filing History |